FDA Brief

Warning letters Food

FDA warning letter to

Todos Medical Ltd aka Todos Medical USA Inc

High riskIssued Nov 7, 2022Posted Mar 28, 2023Center for Food Safety and Applied Nutrition (CFSAN)

FDA warned Todos Medical over selling Tollovid as an unapproved COVID-19 drug and misbranded product.

What happened

FDA reviewed the company’s websites, social media, and Amazon storefront on June 23, 2022. It found Tollovid offered for sale in the U.S. with claims that it can prevent, treat, or cure COVID-19. FDA said the product is an unapproved new drug and misbranded.

What FDA found

  1. Tollovid is an unapproved new drug because it is sold for a COVID-19 use without FDA approval.

    section 505(a) of the FD&C Act, 21 U.S.C. § 355(a)
  2. Tollovid is a misbranded drug under the FD&C Act.

    section 502 of the FD&C Act, 21 U.S.C. § 352
  3. The product cannot be introduced or delivered into interstate commerce.

    sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d)

What FDA wants

FDA tells Todos Medical to stop selling unapproved COVID-19 products immediately and to email the steps it has taken within 48 hours, including how it will prevent repeat violations and supporting documents. If it cannot complete action within 48 hours, it must state why and give a timeline.

Who should pay attention

  • consumers who bought COVID-19 products online
  • retailers and online marketplaces listing supplements
  • supplement companies making disease-treatment claims

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk